Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

These Analysts Increase Their Forecasts On Citigroup After Strong Earnings

Citigroup Inc (NYSE: C) reported better-than-expected earnings for its third quarter on Friday.
byLisa Levin
October 16, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup Inc (NYSE:C) reported better-than-expected earnings for its third quarter on Friday.

Citigroup reported a third-quarter FY23 net revenue increase of 9% year-over-year to $20.14 billion, beating the consensus of $19.32 billion. EPS of $1.63 beat the consensus of $1.21.

Citigroup shares fell 0.3% to trade at $147.63 on Friday.

These analysts made changes to their price targets on Citigroup following earnings announcement.

  • BMO Capital increased the price target on Citigroup from $61 to $66. BMO Capital analyst James Fotheringham maintained an Outperform rating.
  • Oppenheimer boosted the price target on Citigroup from $81 to $82. Oppenheimer analyst Chris Kotowski maintained an Outperform rating.

Check This Out: Top 3 Health Care Stocks That May Implode This Quarter

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

American Medical Association Grants Cardio Diagnostics A Dedicated CPT PLA Reimbursement Code For Epi+Gen CHD, An AI-Powered Test For Assessing The Probability Of A Heart Attack Or Coronary Heart Disease Event

By Benzinga Newsdesk
January 3, 9:32 AM
This is the second CPT PLA code the American Medical Association (AMA) granted for the Company's AI-powered coronary heart disease tests. This significant milestone enables the acceleration of reimbursement for the

CDIO